Algert Global’s Avanos Medical AVNS Stock Holding History

Algert Global’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,011	Closed	-$420K	–	1255
2026 Q1	$420K	Sell	30,011 -54,020	-64%	-$728K	0.01%	983
2025 Q4	$944K	Buy	84,031 +12,381	+17%	+$142K	0.01%	860
2025 Q3	$828K	Buy	71,650 +10,910	+18%	+$128K	0.01%	864
2025 Q2	$743K	Buy	+60,740	New	+$764K	0.02%	861
2024 Q3	–	Sell	-66,476	Closed	-$1.32M	–	1204
2024 Q2	$1.32M	Buy	66,476 +4,646	+8%	+$90.5K	0.04%	599
2024 Q1	$1.23M	Buy	61,830 +32,510	+111%	+$628K	0.05%	560
2023 Q4	$658K	Buy	+29,320	New	+$605K	0.03%	735
2022 Q4	–	Sell	-40,115	Closed	-$874K	–	1135
2022 Q3	$874K	Buy	40,115 +2,039	+5%	+$53.3K	0.05%	597
2022 Q2	$1.04M	Buy	38,076 +18,130	+91%	+$521K	0.08%	452
2022 Q1	$668K	Buy	+19,946	New	+$642K	0.04%	704
2016 Q4	–	Sell	-9,664	Closed	-$335K	–	330
2016 Q3	$335K	Buy	+9,664	New	+$338K	0.1%	288

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Algert Global's AVNS Position: Q2 2026 in Review

Algert Global sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 30,011 shares — an estimated $420K sold.

Algert Global first reported a position in AVNS in Q3 2016 and held it in 11 quarters. The position peaked at $1.32M in Q2 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Algert Global reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
Algert Global sold 30,011 Avanos Medical shares in Q2 2026, an estimated $420K.
Algert Global first reported a position in Avanos Medical in Q3 2016 and held it in 11 quarters.
Algert Global's Avanos Medical position peaked at $1.32M in Q2 2024.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.